GlassScriptPhysician profile
James J Lee
NPI 1225065659
$10,108.48
in general payments reported to CMS, 2019-2025
33 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,166 · 2020: $990 · 2021: $1,403 · 2022: $725 · 2023: $2,790 · 2024: $615 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,851 · Travel and Lodging: $1,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,851.43 |
| Travel and Lodging | $1,973.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $1,828.46 | 2019-2023 | V.A.C. Veraflo Cleanse Choice, Prevena, Activ.A.C. |
| Axogen | $1,570.01 | 2019-2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Musculoskeletal Transplant Foundation INC. | $1,327.75 | 2022-2025 | |
| Allergan, INC. | $1,130.42 | 2019-2022 | |
| Medical Device Business Services, INC. | $1,036.27 | 2019 | |
| Boston Scientific Corporation | $927.82 | 2020-2025 | Emerge Push |
| Smith+Nephew, INC. | $522.66 | 2019-2025 | Stravix, Stravix Pl, Collagenase Santyl |
| Abbvie INC. | $359.70 | 2023-2025 | |
| Integra Lifesciences Corporation | $319.56 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aroa Biosurgery Incorporated | $186.08 | 2023-2024 | |
| Solventum Corporation | $135.44 | 2024-2025 | Activ.A.C., V.A.C.Instill, V.A.C.Ulta |
| Janssen Biotech, INC. | $119.90 | 2020-2024 | Simponi, Simponi Aria, Stelara |
| Regeneron Healthcare Solutions, INC. | $77.01 | 2022-2023 | Dupixent |
| Nevro Corp. | $76.42 | 2019-2022 | |
| Medline Industries LP | $62.88 | 2022-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $56.54 | 2019-2020 | |
| Polynovo North America LLC | $31.05 | 2025 | Novosorb Btm |
| Stryker Corporation | $28.92 | 2023-2025 | Hoffmann, Sonopet Iq |
| Vertex Pharmaceuticals Incorporated | $28.22 | 2025 | |
| Zimmer Biomet Holdings, INC. | $26.58 | 2019 | |
| Gilead Sciences, INC. | $26.32 | 2020 | |
| Osiris Therapeutics INC. | $25.07 | 2019 | |
| Tesaro, INC. | $25.03 | 2019 | |
| Merck Sharp & Dohme LLC | $23.27 | 2022 | |
| Genzyme Corporation | $22.09 | 2023 | |
| Arteriocyte Medical Systems, INC. | $20.73 | 2024 | Magellan |
| Ethicon US, LLC | $20.26 | 2025 | Stratafix |
| Lifenet Health | $19.89 | 2024 | Theragenesis Wound Matrix |
| Saxum Surgical, INC. | $18.21 | 2024 | |
| Mentor Worldwide LLC | $16.52 | 2019 | |
| Heron Therapeutics, INC. | $16.20 | 2025 | Zynrelef |
| Endo Pharmaceuticals INC. | $13.36 | 2022 | |
| Kerecis Limited | $9.84 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.